{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:04:52Z","timestamp":1794085492625,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1U01DP006441"],"award-info":[{"award-number":["1U01DP006441"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001608","name":"EyeSight Foundation of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ajo.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T11:35:13Z","timestamp":1694086513000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Alabama Screening and Intervention for Glaucoma and Eye Health through Telemedicine (AL-SIGHT): Baseline Results"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-011X","authenticated-orcid":false,"given":"Cynthia","family":"Owsley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Gerald","family":"McGwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6994-3571","authenticated-orcid":false,"given":"Van Thi Ha","family":"Nghiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Register","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan M.","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7489-089X","authenticated-orcid":false,"given":"Massimo","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen K.","family":"Antwi-Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Girkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-7669","authenticated-orcid":false,"given":"Lindsay A.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2023.09.001_bib0001","unstructured":"United States Census Bureau. 65 and Older population rapidly grows as boomers age. Published 2020. Accessed June 20, 2023. https:\/\/www.census.gov\/newsroom\/press-releases\/2020\/65-older-population-grows.html."},{"issue":"2","key":"10.1016\/j.ajo.2023.09.001_bib0002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ajo.2012.02.024","article-title":"The changing face of primary open-angle glacuoma in the United States: demographics and geographic changes from 2011 to 2050","volume":"154","author":"Vajaranant","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2023.09.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2023.07.020","article-title":"Trends in the diagnosed prevalence and incidence of major eye diseases in Medicare Part B fee-for-service beneficiaries aged 68 years or older","author":"Ehrlich","year":"2023","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2023.09.001_bib0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2020.21899","article-title":"Glaucoma in adults\u2014screening, diagnosis, and management","volume":"325","author":"Stein","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.001_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amepre.2013.02.018","article-title":"Age-related eye disease and visual impairment among U.S. adults","volume":"45","author":"Chou","year":"2013","journal-title":"Am J Prev Med"},{"issue":"8","key":"10.1016\/j.ajo.2023.09.001_bib0006","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2023.09.001_bib0007","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archopht.121.9.1303","article-title":"Longitudinal prevalence of major eye diseases","volume":"121","author":"Lee","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.09.001_bib0008","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/archopht.126.12.1740","article-title":"Projection of diabetic retinopathy and other major eye diseaes among people with diabetes mellitus: United States, 2005-2050","volume":"126","author":"Saaddine","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2023.09.001_bib0009","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archopht.126.8.1111","article-title":"Prevalence of refractive error in the United States, 1999-2004","volume":"126","author":"Vitale","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2023.09.001_bib0010","unstructured":"Prevent Blindness. Vision problems in the U.S. Prevalence of adult vision impairment and age-related eye disease in America. Accessed June 20, 2023. https:\/\/preventblindness.org\/wp-content\/uploads\/2013\/04\/VPUS_2008_update.pdf."},{"issue":"7","key":"10.1016\/j.ajo.2023.09.001_bib0011","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1167\/iovs.06-0107","article-title":"Perceived barriers to care and attitudes about vision and eye care: focus groups with older African Americans and eye care providers","volume":"47","author":"Owsley","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2023.09.001_bib0012","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/archophthalmol.2011.190","article-title":"Tailored and targeted interventions to encourage dilated fundus examinations in older African Americans","volume":"129","author":"Ellish","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.001_bib0013","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archopht.123.3.387","article-title":"Perceived barriers to diabetic eye care: qualitative study of patients and physicians","volume":"123","author":"Hartnett","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.09.001_bib0014","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5993\/AJHB.32.5.10","article-title":"Factors that influence the receipt of eye care","volume":"32","author":"Alexander","year":"2008","journal-title":"Am J Health Behav"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.001_bib0015","first-page":"115","article-title":"Preliminary evaluation of the InCHARGE program among older African Americans in rural Alabama","volume":"3","author":"Owsley","year":"2010","journal-title":"J Health Dispar Res Pract"},{"key":"10.1016\/j.ajo.2023.09.001_bib0016","series-title":"Making Eye Health a Population Health Imperative: Vision for Tomorrow","author":"Teutsch","year":"2016"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.001_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/tmj.2017.0100","article-title":"Tele-ophthalmology for age-related macular degeneration and diabeteic retinnopathy screening: a systematic review and meta-analysis","volume":"24","author":"Kawagushi","year":"2018","journal-title":"Telemed J E Health"},{"key":"10.1016\/j.ajo.2023.09.001_bib0018","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2147\/OPTH.S171263","article-title":"Two-year outcomes of a pilot glaucoma suspect telemedicine monitoring program","volume":"12","author":"Modjtahedi","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2023.09.001_bib0019","article-title":"Telemedicine across the globe\u2014position paper from the COVID-19 Pandemic Health System Resilience PROGRAM (REPROGRAM) Internatinal Consortium (Part 1)","volume":"8","author":"Bhaskar","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.ajo.2023.09.001_bib0030","unstructured":"Centers for Disease Control and Prevention. Facts about hypertension. Accessed June 20, 2023. https:\/\/www.cdc.gov\/bloodpressure\/facts.htm."},{"key":"10.1016\/j.ajo.2023.09.001_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2023.02.026","article-title":"Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: first year outcomes and implementation costs","volume":"251","author":"Newman-Casey","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2023.09.001_bib0021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajo.2023.01.019","article-title":"Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT): baseline results and costs of a cluster randomized trial","volume":"251","author":"Hark","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.09.001_bib0022","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/IJG.0000000000001794","article-title":"Alabama Screening and Intervention for Glaucoma and Eye Health through Telemedicine (AL-SIGHT): study design and methodology","volume":"30","author":"Rhodes","year":"2021","journal-title":"J Glaucoma"},{"issue":"19","key":"10.1016\/j.ajo.2023.09.001_bib0023","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.3390\/cancers14194824","article-title":"Health burdens and SES in Alabama: using geographic information system to examine prostate cancer health disparity","volume":"14","author":"Aladuwaka","year":"2022","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ajo.2023.09.001_bib0024","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1464-5491.2003.01077.x","article-title":"Grading and disease management in national screening for diabetic retinopathy in England and Wales","volume":"20","author":"Harding","year":"2003","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.ajo.2023.09.001_bib0025","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1167\/iovs.15-18469","article-title":"Prevalence of glaucoma in the United States: the 2005-2008 National Health and Nutrition Examination Survey","volume":"57","author":"Gupta","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2023.09.001_bib0026","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamaophthalmol.2021.0527","article-title":"Prevalence of visual acuity loss or blindness in the US. A Bayesian meta-analysis","volume":"139","author":"Flaxman","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.001_bib0027","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archopht.122.4.552","article-title":"The prevalence of diabetic retinopathy among adults in the United States","volume":"122","author":"Kempen","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2023.09.001_bib0028","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report 2020, estimates of diabetes and its burden in the United States. Accessed June 20, 2023. https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html."},{"key":"10.1016\/j.ajo.2023.09.001_bib0031","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.5888\/pcd19.220027","article-title":"Cardiovascular risk factors in US adults with vision impairment","volume":"19","author":"Mendez","year":"2022","journal-title":"Prev Chronic Dis"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.001_bib0032","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.ijg.0000243481.75155.97","article-title":"The results of screening frequency doubling technology perimetry in different locations of the community","volume":"16","author":"Mansberger","year":"2007","journal-title":"J Glaucoma"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.001_bib0033","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0002-9394(01)01380-0","article-title":"Community screening for eye disease by laypersons: the Hoffberger program","volume":"133","author":"Quigley","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.001_bib0034","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1353\/hpu.2013.0134","article-title":"Barriers to attending an eye examination after vision screening referral within a vulnerable population","volume":"24","author":"Gower","year":"2013","journal-title":"J Health Care Poor Underserved"},{"issue":"8","key":"10.1016\/j.ajo.2023.09.001_bib0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/IJG.0000000000000716","article-title":"Adherence to follow-up recommendations among individuals in the Philadelphia Glaucoma Detection and Treatment Project","volume":"26","author":"Hark","year":"2017","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2023.09.001_bib0036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajo.2018.01.008","article-title":"Improving follow-up and reducing barriers for eye screenings in communities: the SToP Glaucoma Study","volume":"188","author":"Zhao","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2023.09.001_bib0037","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaophthalmol.2016.3081","article-title":"Patients' adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use","volume":"134","author":"Keenum","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.001_bib0038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10900-014-9890-2","article-title":"Providing prescheduled appointments as a strategy for improving follow-up compliance after community-based glaucoma screening: results from an urban underserved population","volume":"40","author":"van Zyl","year":"2015","journal-title":"J Community Health"},{"key":"10.1016\/j.ajo.2023.09.001_bib0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/PROM.S98686","article-title":"Eye Care Quality and Accessibility Improvement in the Community (EQUALITY): impact of an eye health education program on patient knowledge about glaucoma and attitudes about eye care","volume":"7","author":"Rhodes","year":"2016","journal-title":"Patient Relat Outcome Meas"},{"issue":"15","key":"10.1016\/j.ajo.2023.09.001_bib0040","first-page":"3920","article-title":"Assessing the reliability of Humphrey Visual Field testing in an urban population","volume":"54","author":"Peracha","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.001_bib0041","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaophthalmol.2014.3609","article-title":"Role of visual field reliability indices in ruling out glaucoma","volume":"133","author":"Rao","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2023.09.001_bib0042","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0161-6420(90)32467-3","article-title":"Screening for glaucomatous visual field loss. The effect of patient reliability","volume":"97","author":"Katz","year":"1990","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423003574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423003574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:54:24Z","timestamp":1757598864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423003574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":41,"alternative-id":["S0002939423003574"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.09.001","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alabama Screening and Intervention for Glaucoma and Eye Health through Telemedicine (AL-SIGHT): Baseline Results","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}